|
Clinical trial participant
|
|
Yes
|
1833
|
1543
|
119
|
–
|
–
|
|
No
|
0
|
434
|
48
|
–
|
–
|
|
Case/control status
|
|
Case
|
–
|
987
|
91
|
–
|
–
|
|
Control
|
–
|
990
|
76
|
–
|
–
|
|
Age mean (SD)
|
63.2 (7.1)
|
64.6 (7.1)
|
66.2 (7.2)
|
59.9 (5.4)
|
56.6 (5.9)
|
|
Sex
|
|
Female
|
1833
|
1977
|
167
|
611
|
1574
|
|
Male
|
0
|
0
|
0
|
448
|
887
|
|
Ethnicity
|
|
White
|
922
|
944
|
99
|
1059
|
0
|
|
African American
|
474
|
631
|
49
|
0
|
2461
|
|
Hispanic/Latino
|
260
|
402
|
16
|
0
|
0
|
|
Asian or Pacific Islander
|
107
|
0
|
2
|
0
|
0
|
|
American Indian or Alaskan Native
|
41
|
0
|
1
|
0
|
0
|
|
Other
|
29
|
0
|
0
|
0
|
0
|
|
Smoking status
|
|
Former and current
|
853
|
913
|
99
|
610
|
1351
|
|
Never
|
963
|
1048
|
67
|
449
|
1110
|
|
Metabolic health status
|
|
Metabolically healthy
|
1254
|
1163
|
109
|
662
|
1177
|
|
Metabolically unhealthy
|
579
|
814
|
58
|
397
|
1284
|
|
BMI*Metabolic Health Z score mean (SD)
|
2.96 (30.38)
|
2.92 (31.59)
|
2.84 (30.4)
|
2.55 (29.0)
|
2.82 (31.4)
|
|
BMI mean (SD)
|
29.5 (5.9)
|
29.8 (6.1)
|
29.3 (6.9)
|
26.2 (4.3)
|
30.1 (6.2)
|
|
BMI categories
|
|
Underweight
|
7
|
13
|
0
|
20
|
18
|
|
Normal
|
417
|
420
|
41
|
435
|
444
|
|
Overweight
|
641
|
680
|
67
|
429
|
912
|
|
Obese
|
768
|
864
|
59
|
175
|
1087
|
|
Waist circumference mean (SD)
|
89.5 (13.8)
|
90.7 (13.7)
|
89.1 (15.1)
|
94.5 (12.8)
|
101.4 (15.1)
|
|
Triglycerides mean (SD)
|
153 (88.2)
|
146.9 (83.4)
|
143.8 (82.5)
|
140.4 (83.6)
|
117.3 (77.7)
|
|
HDL-cholesterol mean (SD)
|
58 (15.1)
|
52.1 (13.2)
|
53.2 (13.0)
|
52.3 (18.2)
|
53.3 (17.3)
|
|
Systolic blood pressure mean (SD)
|
128 (18)
|
132.1 (17.8)
|
132.5 (16.6)
|
118.7 (18.0)
|
127.3 (20.6)
|
|
Diastolic Blood Pressure mean (SD)
|
75.3 (9.4)
|
76.4 (9.3)
|
76.3 (8.5)
|
68.5 (9.7)
|
75.2 (10.7)
|
|
Blood glucose mean (SD)
|
103 (31.1)
|
108.6 (41.3)
|
105.2 (37.2)
|
105.9 (28.6)
|
129.3 (64.3)
|
